Search

Your search keyword '"Belderbos, J."' showing total 6 results
Start Over Author "Belderbos, J." Language dutch; flemish
6 results on '"Belderbos, J."'

1. Perspectieven in de behandeling van het niet-kleincellige longcarcinoom stadium III met radiotherapie en gelijktijdig gegeven laaggedoseerde chemotherapie

Author

Uitterhoeve, A. L. J., Belderbos, J. S. A., van Zandwijk, N., Koning, C. C. E., Cancer Center Amsterdam, and Radiotherapy

Abstract

Patients with a non-small cell lung cancer stage III should preferably be treated with a combination of concomitant radiotherapy and platinum-containing chemotherapy. Concomitant chemoradiation results in improved survival compared to sequential chemoradiation, although this type oftreatment is associated with higher oesophagus toxicity. With concomitant chemoradiation the chemotherapy can be added in several ways to high-dosage radiotherapy, for example in the form of 2 courses of high dose, platinum-containing polychemotherapy once every 3 weeks. Concomitant chemoradiation with just a daily low dose of cisplatin is a good alternative. In view of its low risk of haematological and renal toxicity and ototoxicity and smaller cardiac load this is the therapy of choice and is also highly suitable for elderly patients with comorbidity

Published
2008

3. M031VC (CKTO 2003-04)

Author

Uitterhoeve, A. L. J., Belderbos, J. S. A., and Radiotherapy

Published
2004

4. [Perspectives in the treatment of non-small cell lung cancer stage III with radiotherapy and concomitant low-dosage chemotherapy].

Author

Uitterhoeve AL, Belderbos JS, van Zandwijk N, and Koning CC

Subjects
Carcinoma, Non-Small-Cell Lung drug therapy, Carcinoma, Non-Small-Cell Lung mortality, Carcinoma, Non-Small-Cell Lung radiotherapy, Dose-Response Relationship, Drug, Drug Administration Schedule, Humans, Lung Neoplasms drug therapy, Lung Neoplasms mortality, Lung Neoplasms radiotherapy, Neoplasm Staging, Remission Induction, Survival Analysis, Treatment Outcome, Carcinoma, Non-Small-Cell Lung therapy, Combined Modality Therapy, Lung Neoplasms therapy
Abstract

Patients with a non-small cell lung cancer stage III should preferably be treated with a combination of concomitant radiotherapy and platinum-containing chemotherapy. Concomitant chemoradiation results in improved survival compared to sequential chemoradiation, although this type oftreatment is associated with higher oesophagus toxicity. With concomitant chemoradiation the chemotherapy can be added in several ways to high-dosage radiotherapy, for example in the form of 2 courses of high dose, platinum-containing polychemotherapy once every 3 weeks. Concomitant chemoradiation with just a daily low dose of cisplatin is a good alternative. In view of its low risk of haematological and renal toxicity and ototoxicity and smaller cardiac load this is the therapy of choice and is also highly suitable for elderly patients with comorbidity.

Published
2008

5. [Pleural mesothelioma in family practice; complicated pain problems].

Author

Belderbos JS, Aleman BM, Boersma LJ, Schouwink JH, and Bartelink H

Subjects
Family Practice, Humans, Mesothelioma radiotherapy, Palliative Care, Pleural Neoplasms radiotherapy, Mesothelioma complications, Pain radiotherapy, Pleural Neoplasms complications
Published
1997

Catalog

Books, media, physical & digital resources
See catalog results